OCT biomarkers as predictors of visual improvement in diabetic macular edema eyes receiving dexamethasone implants.
Giacomo VisioliLudovico AlisiElvia MastrogiuseppeGiuseppe Maria AlbaneseEnrico RomanoLudovico IannettiMarta ArmentanoFrancesca GiovannettiMagda GharbiyaPublished in: International journal of retina and vitreous (2023)
Our analyses suggest that a ticker baseline CST may serve as a positive predictor of early visual improvement and SND presence at baseline may be a negative prognostic factor for CST increase 4 months after DEX-I injection. Other well-known biomarkers, such as disorganization of the inner retinal layers (DRIL) and hyperreflective foci (HF), did not demonstrate prognostic value on visual outcomes, at least within the first four months following the injection.